Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment

被引:0
作者
Arnold Bolomsky
Karin Schlangen
Wolfgang Schreiner
Niklas Zojer
Heinz Ludwig
机构
[1] Department of Medicine I,Wilhelminen Cancer Research Institute
[2] Wilhelminenspital,Center for Medical Statistics, Informatics and Intelligent Systems
[3] Medical University of Vienna,undefined
来源
Journal of Hematology & Oncology | / 9卷
关键词
Multiple myeloma; BMI-1; PTC-209; Microenvironment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 285 条
  • [1] Palumbo A(2011)Multiple myeloma N Engl J Med 364 1046-1060
  • [2] Anderson K(2014)Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients Leukemia 28 1122-1128
  • [3] Kumar SK(2011)BMI1 as a novel target for drug discovery in cancer J Cell Biochem 112 2729-2741
  • [4] Dispenzieri A(1991)Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice Cell 65 753-763
  • [5] Lacy MQ(1993)bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis Oncogene 8 3161-3164
  • [6] Gertz MA(2005)Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1 Mol Cell Biol 25 11047-11058
  • [7] Buadi FK(2005)Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing Mol Cell 20 845-854
  • [8] Pandey S(2006)Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells Cancer Res 66 6225-6232
  • [9] Cao L(2008)Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma J Cancer Res Clin Oncol 134 535-541
  • [10] Bombard J(2012)Overexpression of BMI-1 is associated with poor prognosis in cervical cancer Asia Pac J Clin Oncol 8 e55-e62